Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/18/2025

Adverse Effects of Evolocumab

Introduction to Evolocumab Side Effects

  • The American College of Cardiology notes that evolocumab's adverse effects primarily include nasopharyngitis, upper respiratory tract infection, influenza, back pain, and injection site reactions 1
  • The American College of Cardiology recommends considering evolocumab for patients who cannot tolerate statins due to muscle symptoms, as PCSK9 inhibitors like evolocumab work through a completely different mechanism that does not affect muscle metabolism 3
  • Clinical trials, including the FOURIER trial with over 27,500 patients, have found no differences in the rates of muscle-related events between evolocumab and placebo groups, with muscle-related events occurring at rates similar to placebo 2, 4

Benefit-Risk Profile

  • The American College of Cardiology notes that the significant LDL-C reduction (50-65%) provided by evolocumab outweighs the minimal risk of muscle-related adverse events 3